Wed, February 12, 2020
Tue, February 11, 2020
Mon, February 10, 2020

Christopher Marai Maintained (ALNY) at Sell with Increased Target to $75 on, Feb 11th, 2020

Christopher Marai of Nomura, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Sell with Increased Target from $62 to $75 on, Feb 11th, 2020.

Christopher has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Friday, February 7th, 2020
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $190 on, Thursday, December 19th, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $176 on, Wednesday, December 18th, 2019
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $143 on, Monday, November 25th, 2019
  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019